← back to search

Stefan Mahrhold

Medizinische Hochschule Hannover · DE
Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research focused on Synaptic vesicle and Binding site, with related work in Receptor, Endocytosis, Neurotoxin. Notable publications include 'N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A', 'Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E', and 'Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A'.
h-index
citations
422
works
10
NIH funding
primary concept
email

Recent publications

Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG‐Syt1‐SV2 plasma membrane nanocluster for synaptic vesicle entry
The EMBO Journal 2023cited by 31position: middledoi
Synaptotagmin 1 mediates toxicity of botulinum neurotoxin type A
bioRxiv (Cold Spring Harbor Laboratory) 2022cited by 0position: middledoi
Functional detection of botulinum neurotoxin serotypes A to F by monoclonal neoepitope-specific antibodies and suspension array technology
Scientific Reports 2019cited by 42position: middledoi
A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency
PLoS Pathogens 2018cited by 34position: middledoi
N-linked glycosylation of SV2 is required for binding and uptake of botulinum neurotoxin A
Nature Structural & Molecular Biology 2016cited by 118position: middledoi
Botulinum Neurotoxin Serotype A Recognizes Its Protein Receptor SV2 by a Different Mechanism than Botulinum Neurotoxin B Synaptotagmin
Toxins 2016cited by 36position: middledoi
Only the complex N559-glycan in the synaptic vesicle glycoprotein 2C mediates high affinity binding to botulinum neurotoxin serotype A1
Biochemical Journal 2016cited by 31position: firstdoi
Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A
FEBS Letters 2014cited by 44position: middledoi
Identification of the SV2 protein receptor-binding site of botulinum neurotoxin type E
Biochemical Journal 2013cited by 46position: firstdoi
Neutralisation of specific surface carboxylates speeds up translocation of botulinum neurotoxin type B enzymatic domain
FEBS Letters 2013cited by 40position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Andreas Rummel · Medizinische Hochschule Hannover10 papers (2013–2023)Daniel Stern · Robert Koch Institute5 papers (2016–2019)Jasmin Weisemann · Medizinische Hochschule Hannover4 papers (2013–2019) · 4 papers (2016–2019)Nadja Krez · Medizinische Hochschule Hannover4 papers (2013–2023)Thomas Binz · Medizinische Hochschule Hannover3 papers (2013–2014)Christopher Small · The University of Queensland2 papers (2022–2023)Anmin Jiang · Hunan University of Science and Technology2 papers (2022–2023) · 2 papers (2018–2019)Michael A. Cousin · University of Edinburgh2 papers (2022–2023)Frédéric A. Meunier · Imperial College London2 papers (2022–2023)Brett M. Collins · Her Majesty's Revenue and Customs2 papers (2022–2023)Justin J. Cooper‐White · Australian Research Council2 papers (2022–2023)Jianlong Lou · San Francisco General Hospital2 papers (2013–2014)Ailisa Blum · The University of Queensland2 papers (2022–2023)Robert G. Parton · O'Brien Institute2 papers (2022–2023)James Rae · University of Queensland2 papers (2022–2023)James D. Marks · San Francisco General Hospital2 papers (2013–2014)Ruby Cooper‐White · University of Queensland2 papers (2022–2023)Giuseppe Balistreri · University of Helsinki2 papers (2022–2023)